Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2.
about
Mesenchymal stem cells promote liver regeneration and prolong survival in small-for-size liver grafts: involvement of C-Jun N-terminal kinase, cyclin D1, and NF-κB.Pim-2/mTORC1 Pathway Shapes Inflammatory Capacity in Rheumatoid Arthritis Synovial Cells Exposed to Lipid Peroxidations.Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.Naringin in Ganshuang Granule suppresses activation of hepatic stellate cells for anti-fibrosis effect by inhibition of mammalian target of rapamycin.Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice.mTOR Signaling Regulates Protective Activity of Transferred CD4+Foxp3+ T Cells in Repair of Acute Kidney Injury.Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis.Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration.Facilitated physiological adaptation to prolonged circadian disruption through dietary supplementation with essence of chicken.The effect of rapamycin on TGFβ1 and MMP1 expression in a rabbit model of urethral stricture.Research progress on signaling pathways in cirrhotic portal hypertension
P2860
Q34639541-DB5D28C3-B422-4BB9-8000-BF41024ACF01Q35614201-AAFEA494-4595-4004-B8B9-19FF899D1FF1Q35651447-85ABA5B0-8910-447E-81ED-13C9F9A101E0Q35886555-F6AD186F-1878-42A5-BE4A-3FEE7800B7E7Q37662925-FCCB77DE-61BF-4B77-BAEA-6192AEB7F35DQ46448963-3E8459B3-B19B-4950-B918-8805601F60F1Q48037675-F3E0E8F0-3976-4A8C-B540-19F519C7E764Q48242025-B4F887E1-A2DE-4B75-A088-A5AC079121D7Q49438485-0DBDC0A3-9499-4202-B801-CEFC1C7B815DQ50876050-4394D976-A542-4DA3-94F2-BA6503613311Q51634091-12825999-E49C-469F-A042-8AAA1768099FQ53186790-E1E867D2-F72A-45C9-858F-98B47867407DQ57069571-7DC98E4D-E1B0-4481-A9D0-A90876BB5171
P2860
Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Rapamycin ameliorates inflamma ...... tion of mTORC1 but not mTORC2.
@en
type
label
Rapamycin ameliorates inflamma ...... tion of mTORC1 but not mTORC2.
@en
prefLabel
Rapamycin ameliorates inflamma ...... tion of mTORC1 but not mTORC2.
@en
P2093
P2860
P1433
P1476
Rapamycin ameliorates inflamma ...... tion of mTORC1 but not mTORC2.
@en
P2093
Chenghong Peng
Hongwei Li
Huakai Wang
Mingjun Zhang
Minmin Shi
Weijie Wang
Weiping Yang
P2860
P304
P356
10.1371/JOURNAL.PONE.0083908
P407
P577
2014-01-03T00:00:00Z